These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 6331645)

  • 1. Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on benzo(a)pyrene toxicity and transforming activity for in vitro-cultured human skin fibroblasts.
    Feo F; Pirisi L; Pascale R; Daino L; Frassetto S; Garcea R; Gaspa L
    Cancer Res; 1984 Aug; 44(8):3419-25. PubMed ID: 6331645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glucose-6-phosphate dehydrogenase deficiency on the benz(a)pyrene toxicity for in vitro cultured human skin fibroblasts.
    Pirisi L; Pascale R; Daino L; Frassetto S; La Spina V; Zanetti S; Gaspa L; Ledda GM; Garcea R; Feo F
    Res Commun Chem Pathol Pharmacol; 1982 Nov; 38(2):301-11. PubMed ID: 6298917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts.
    Pascale R; Ruggiu ME; Simile MM; Daino L; Vannini G; Seddaiu MA; Satta G; Feo F
    Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):361-4. PubMed ID: 2236903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory mechanisms of chemical carcinogenesis: the role of the NADPH pool in the benzo(a)pyrene activation.
    Feo F; Pirisi L; Pascale R; Daino L; Frassetto S; Zanetti S; Garcea R
    Toxicol Pathol; 1984; 12(3):261-8. PubMed ID: 6440265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of glucose-6-phosphate dehydrogenase deficiency on the formation of mutagenic and carcinogenic metabolites derived from benzo(a)pyrene.
    Pirisi L; Garcea R; Pascale R; Ruggiu ME; Feo F
    Toxicol Pathol; 1987; 15(1):115-9. PubMed ID: 3576073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of benzo(a)pyrene by transformable and nontransformable C3H mouse fibroblasts in culture.
    Gehly EB; Heidelberger C
    Cancer Res; 1982 Jul; 42(7):2697-2704. PubMed ID: 6282446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzo(a)pyrene metabolism by lymphocytes from normal individuals and individuals carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase.
    Feo F; Ruggiu ME; Lenzerini L; Garcea R; Daino L; Frassetto S; Addis V; Gaspa L; Pascale R
    Int J Cancer; 1987 May; 39(5):560-4. PubMed ID: 3570548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of benzo(a)pyrene in epidermal keratinocytes and dermal fibroblasts of humans and mice with reference to variation among species, individuals, and cell types.
    Kuroki T; Hosomi J; Munakata K; Onizuka T; Terauchi M; Nemoto N
    Cancer Res; 1982 May; 42(5):1859-65. PubMed ID: 6279285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct suppression of in vitro antibody production by mouse spleen cells by the carcinogen benzo(a)pyrene but not by the noncarcinogenic congener benzo(e)pyrene.
    White KL; Holsapple MP
    Cancer Res; 1984 Aug; 44(8):3388-93. PubMed ID: 6331644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of benzo(a)pyrene by human epithelial and fibroblastic cells: metabolite patterns and DNA adduct formation.
    Bartley J; Bartholomew JC; Stampfer MR
    J Cell Biochem; 1982; 18(2):135-48. PubMed ID: 6279686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of dihydrodiol metabolites of benzo(alpha)pyrene in cultured human and murine skin cells.
    Hukkelhoven MW; Vromans E; Vermorken AJ; Bloemendal H
    Anticancer Res; 1982; 2(1-2):89-94. PubMed ID: 7202342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phenols as toxic metabolites of benz(a)pyrene].
    Belitskiĭ GA; Riabykh TP; Kobliakov VA
    Tsitologiia; 1977 Oct; 19(10):1193-6. PubMed ID: 564091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer simulation of the metabolic consequences of the combined deficiency of 6-phosphogluconolactonase and glucose-6-phosphate dehydrogenase in human erythrocytes.
    Thorburn DR; Kuchel PW
    J Lab Clin Med; 1987 Jul; 110(1):70-4. PubMed ID: 3598338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the thymidine kinase gene after in vitro modification with benzo(a)pyrene-diol-epoxide and transfer to LTK- cells as a eukaryotic test for carcinogens.
    Schaefer-Ridder M; Moeroey T; Engelhardt U
    Cancer Res; 1984 Dec; 44(12 Pt 1):5861-6. PubMed ID: 6437673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal dynamics of cortisol and dexamethasone prevention of benzo(a)pyrene-induced morphological transformation of Syrian hamster cells.
    Greiner JW; Evans CH
    Cancer Res; 1982 Oct; 42(10):4014-7. PubMed ID: 6286103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis.
    Nakayama J; Yuspa SH; Poirier MC
    Cancer Res; 1984 Sep; 44(9):4087-95. PubMed ID: 6331664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoplastic transformation of human lung fibroblast MRC-5 SV2 cells induced by benzo[a]pyrene and confluence culture.
    Zhu H; Gooderham N
    Cancer Res; 2002 Aug; 62(16):4605-9. PubMed ID: 12183415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-6-phosphate dehydrogenase-deficient cells show an increased propensity for oxidant-induced senescence.
    Cheng ML; Ho HY; Wu YH; Chiu DT
    Free Radic Biol Med; 2004 Mar; 36(5):580-91. PubMed ID: 14980702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzo[a]pyrene dione-benzo[a]pyrene diol oxidation-reduction couples; involvement in DNA damage, cellular toxicity, and carcinogenesis.
    Lesko SA; Lorentzen RJ
    J Toxicol Environ Health; 1985; 16(5):679-91. PubMed ID: 3005601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of benzo(a)pyrene-induced transformation of C3H/10T1/2 cells by allylisopropylacetamide and isopropylvaleramide.
    Kuszynski C; Somogyi A; Nesnow S; Langenbach R
    Cancer Res; 1981 May; 41(5):1893-7. PubMed ID: 6260354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.